| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_674a44c3a05e9046f9ee4339f0fbf23d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3967dd07f3c2357cd8e32aa7e89f8f40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49068eb9a7168e6adf24b50ee6c096e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7166cd0ea1f581471000c7c212e45a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_414b2a4985ef2b89a2a1ff36b0c23380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c9f40b903e3c912586a8ad100c134fa |
| publicationDate |
2013-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013137782-A1 |
| titleOfInvention |
Agent for the treatment of hepatitis c virus |
| abstract |
The invention relates to medicine and comprises an agent for the treatment of hepatitis C virus in the form of glutaryl histamine or a pharmaceutically acceptable salt thereof. This agent can also be introduced in combination with a pegylated interferon and ribavirin. The invention also relates to a pharmaceutical composition for the treatment of hepatitis C virus. This invention solves the problem of providing a novel agent which is effective in the treatment of hepatitis C virus and makes it possible to produce a sustained virologic response. |
| priorityDate |
2012-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |